Vasculitis and Oral Health

May 2011 By John Mills, BDS, DGDP UK, Chairman, Vasculitis UK Vasculitis can affect all parts of the body and the mouth is no exception. Large, persistent and excruciatingly painful more »


Read More

FDA Approval of Rituxan for Wegener’s and Microscopic Polyangiitis

April 2011 On April 19, 2011, the U.S. Food and Drug Administration approved the drug, Rituxan®, (rituximab) in combination with glucocorticosteroids for the treatment of two forms of ANCA-associated vasculitis: more »


Read More

Supporting International Research for Rare Diseases

April 2011 Two recent workshops sponsored by the European Commission, Health Directorate, DG Research and Innovation, and the US National Institutes of Health Office of Rare Diseases Research (ORDR), focused more »


Read More

New Horizons Discovered for GCA Treatment

January 2011 By Cornelia Weyand, MD, PhD New research from Stanford University has identified three molecules that play a role in the abnormal immune responses of GCA. The discovery may more »


Read More

NIH Launches Second Phase of Patient Reported Outcomes Initiative

January 2011 The National Institutes of Health (NIH) announced that it is awarding 15 new grants to further develop and test the Patient Reported Outcomes Measurement Information System (PROMIS). Managed more »


Read More